Baseline pathogenic mutations in non-AR/non-TP53 genes and prediction of response to high-dose testosterone.
JOURNAL OF CLINICAL ONCOLOGY(2021)
Abstract
146Background: The fact that high dose of testosterone (HDT) elicits positive responses in a subset of prostate cancer patients (pts) is surprising and puzzling. Genomics data differentiating respo...
MoreTranslated text
Key words
testosterone,baseline pathogenic mutations,high-dose
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined